COOKSON PEIRCE & CO INC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.

Quarter-by-quarter ownership
COOKSON PEIRCE & CO INC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$65
-99.9%
50,000
+316.7%
0.00%0.0%
Q3 2022$59,000
-96.2%
12,000
-87.9%
0.00%
-96.2%
Q4 2020$1,545,000
+194.3%
99,030
+258.2%
0.10%
+118.8%
Q1 2018$525,000
+27.4%
27,650
+10.0%
0.05%
+23.1%
Q4 2017$412,000
-40.5%
25,140
-45.6%
0.04%
-45.8%
Q3 2017$693,000
+118.6%
46,200
+28.4%
0.07%
+100.0%
Q2 2017$317,00035,9900.04%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RA Capital Management 6,000,000$66,540,0006.69%
FIC CAPITAL INC 787,529$8,734,0003.47%
RA Capital Management 1,220,209$13,532,0001.36%
PRINCETON CAPITAL MANAGEMENT INC 114,120$1,266,0000.67%
Perceptive Advisors 800,000$8,872,0000.53%
Cormorant Asset Management, LP 361,000$4,003,0000.53%
Highlander Capital Management, LLC 43,500$482,0000.43%
APEX CAPITAL, LLC 439,900$4,878,0000.42%
WASATCH ADVISORS LP 3,091,386$34,283,0000.37%
Baker Brothers Advisors 3,230,932$35,831,0000.31%
View complete list of SANGAMO THERAPEUTICS INC shareholders